Laboratory Services

Breast Carcinoma-Associated Antigen, Serum

Print this page

Updated Test Information:

Test Description
Breast Carcinoma-Associated Antigen, Serum
Synonym(s)

Biomira Truquant BR|Breast Cancer Tumor Markers|Breast Carcinoma|Cancer Antigen 27.29 (CA 27.29)|MAM 6|Milk Mucin|CA2729

Test ID
C2729
General Information

USEFUL FOR
Serial testing in women with prior stage II or III breast cancer who are clinically free of disease


Predicting early recurrence of disease in women with treated carcinoma of the breast


Indicating that additional tests or procedures should be performed to confirm recurrence of breast cancer


This test is not useful for screening women for carcinoma of the breast

Container Type

SST

Specimen Type

Serum

Specimen Requirements

0.5 mL

Alternate Specimen Type

Red Top Serum

Specimen Collection / Processing Instructions

1. Centrifuge and aliquot serum into a plastic vial within 2 hours of collection. Specimens that have not been aliquoted will be canceled. 2. Send refrigerated.

Minimum Sample Volume

0.25mL

Stability

Refrigerated (preferred) 7 days|Frozen 90 days|Ambient 4 days

Unacceptable Specimen Conditions

Gross hemolysis

Methodology

Chemiluminometric Immunoassay

Estimated TAT

Same day/1 to 2 days

Testing Schedule

Monday through Friday

CPT Code(s)

86300

Reference Range

Males > or =18 years: < or =38.0 U/mL (use not defined). Females> or =18 years: < or =38.0 U/mL. Reference values have not been established for patients who are younger than 18 years of age. Serum markers are not specific for malignancy, and values may vary by method.

STAT Orderable (Y/N)

N

Performing Lab

Mayo

LOINC Code(s)

17842-6